Ozempic
Regulator investigates Ozempic suicidal ideation link
Novo Nordisk’s diabetes medication, Ozempic (semaglutide) and weight-loss treatment Saxenda (liraglutide) are being investigated, following reports they may be associated with suicidal ideation The European Medicines Agency (EMA) is looking …
Ozempic shortage pain to continue until year’s end
TGA underscores ‘limited availability’ means drug should still only be prescribed for type-2 diabetes There will be continued “limited availability” of diabetes drug Ozempic until 31 December 2023 due to …
Semaglutide cancer and depression risks investigation
Concerns Ozempic ingredient may be related to thyroid cancer and suicide ideation draws attention of EMA Semaglutide, the active ingredient in hyped diabetes and weight loss drug, Ozempic and others, …
Telehealth prescribing crackdown looms
New guidelines this week will ban “tick-and-flick” online “consultations” The Medical Board will hand down new guidelines on Thursday (June 1 2023) that will stop telehealth doctors from prescribing to …
Oral semaglutide as effective as injectable
Ozempic/Wegovy sponsor trumpets results of Phase III clinical trial as its halts US ads A trial of an oral version of Novo Nordisk’s obesity and diabetes medication semaglutide, the active …
Fake Ozempic discovered; TGA
Test of two separate imports showed they contained no semaglutide As the Ozempic shortage continues at least until the end of June, the Therapeutic Goods Administration (TGA) has detected counterfeit …
The week in review
Two opposing forces lobbied for different ways to save patients money this week, while there was lots of medicines news and we looked at burnout in hospitals There was bad …
Twomey takes to Sunrise with Ozempic warning
Australians looking to access supplies of diabetes medication Ozempic (semaglutide) are being urged not to source the drug online Patients turning to Google to find supplies of Ozempic are putting …
The week in review
Double dispensing, pharmacist prescribing and women in pharmacy were all key issues which made the news this week We heard that some health practitioners have had their details stolen in …
Guard your professional identity, warns group
One pharmacy stakeholder is worried that some prescribers’ identities have been stolen to make an Ozempic scam look more convincing And pharmacists concerned the same could have happened to them …
Ozempic scams abound, TGA warns
As shortage eases, regulator tells consumers to only deal with Australian pharmacies when buying the medicine The Therapeutic Goods Administration (TGA) has warned consumers to only obtain the shortage-plagued diabetes …